ipoGoogle News
148 IPOs Are Waiting: Can India’s Markets Absorb the Rush? | TMB Decode - The Economic Times
148 IPOs Are Waiting: Can India’s Markets Absorb the Rush? | TMB Decode The Economic Times
GN1 hour ago
Read More//
Arch Pharmalabs Limited Unlisted / Pre-IPO Share Price
As of 25 Sept 2026, the Arch Pharmalabs Limited unlisted share price is ₹85 per share. Arch Pharmalabs Limited is an unlisted / pre-IPO company — not listed on NSE or BSE. ISIN: INE182F01017.
▼ ₹47 (−35.61%) over all time
Key figures for Arch Pharmalabs Limited
Arch Pharmalabs Limited is an unlisted share opportunity tracked by Safal Capital. Detailed company information will be updated as verified data becomes available.
Arch Pharmalabs Limited shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. Arch Pharmalabs Limited is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “Arch Pharmalabs Limitedshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Arch Pharmalabs Limited has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for Arch Pharmalabs Limited is INE182F01017. Contact our desk for the latest status and a live quote before you invest.
As of 25 Sept 2026, the Arch Pharmalabs Limited unlisted (pre-IPO) share price is ₹85 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
You buy Arch Pharmalabs Limited unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. Arch Pharmalabs Limited is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Arch Pharmalabs Limited has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on Arch Pharmalabs Limited.
Arch Pharmalabs Limited is an unlisted company operating in the this sector sector. Detailed company information is available on request.
The current unlisted market price is ₹85 per share. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
148 IPOs Are Waiting: Can India’s Markets Absorb the Rush? | TMB Decode The Economic Times
Indian stock market will double in five years, says Motilal Oswal’s Raamdeo Agrawal Financial Times
The ISIN for Arch Pharmalabs Limited unlisted shares is INE182F01017. You will need this ISIN when the shares are credited to your demat account.
Arch Pharmalabs Limited unlisted shares have a face value of ₹10 and a typical minimum lot of 250 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The Arch Pharmalabs Limited price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like Arch Pharmalabs Limited can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess Arch Pharmalabs Limited.
Sensex, Nifty 50 prediction today: Stock market outlook for 25 Sept 2026 | GIFT Nifty, Nikkei, Taiwan cues to watch Livemint